<DOC>
	<DOCNO>NCT00738296</DOCNO>
	<brief_summary>Comparison effect progression carotid intima-media interphase thickness ( GIM ) , arterial rigidity accord measurement pulse wave speed direct measurement carotid aortic rigidity inflammation marker ( PCR ) patient establish cardiovascular disease ( myocardial infarct , atherosclerotic coronary disease ) , diabetes mellitus type 2 equivalent risk coronary disease low density lipoprotein level &gt; 100 mg/dL , treat simvastatin , pravastatin combination simvastatin-ezetimibe period least one year .</brief_summary>
	<brief_title>Vytorin Carotid Intima-media Thickness Overall Rigidity</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>LdlC Levels &gt; 100 Mg/Dl Patients Who Have Signed The Consent Patients Of age 30 75 Years Old Patients Of Both Genders Patients With Established Cardiovascular Disease , Diabetes With Or Without Established Cardiovascular Disease Patients Without Previous Treatment With Ezetimibe</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>